{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:14:33Z","timestamp":1791328473172,"version":"4.3.1"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T00:00:00Z","timestamp":1405382400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0102664","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T17:28:27Z","timestamp":1405445307000},"page":"e102664","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Efficacy of Imiquimod-Based Transcutaneous Immunization Using a Nano-Dispersed Emulsion Gel Formulation"],"prefix":"10.1371","volume":"9","author":[{"given":"Pamela","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Gogoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Tenzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansj\u00f6rg","family":"Schild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Stevanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Langguth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus P.","family":"Radsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,7,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2010.09.018","article-title":"Advances in transcutaneous vaccine delivery: do all ways lead to Rome?","volume":"148","author":"SM Bal","year":"2010","journal-title":"J Control Release"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1586\/14760584.7.9.1329","article-title":"Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook","volume":"7","author":"JA Mikszta","year":"2008","journal-title":"Exp Rev Vaccines"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/heapro\/dah110","article-title":"Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses","volume":"19","author":"M Kermode","year":"2004","journal-title":"Health Promot Int"},{"key":"ref4","first-page":"808","article-title":"The cost of unsafe injections","volume":"77","author":"E Pisani","year":"1999","journal-title":"Bulletin of the World Health Organization"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/jid.2010.254","article-title":"UV exposure boosts transcutaneous immunization and improves tumor immunity: cytotoxic T-cell priming through the skin","volume":"131","author":"P Stein","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/36014","article-title":"Skin immunization made possible by cholera toxin","volume":"391","author":"GM Glenn","year":"1998","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jconrel.2009.09.005","article-title":"Shielding the cationic charge of nanoparticle-formulated dermal DNA vaccines is essential for antigen expression and immunogenicity","volume":"141","author":"JH van den Berg","year":"2010","journal-title":"Journal of Controlled Release"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.4049\/jimmunol.174.5.2476","article-title":"Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod","volume":"174","author":"G Rechtsteiner","year":"2005","journal-title":"J Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02686082","article-title":"Transcutaneous immunization with imiquimod is amplified by CD40 ligation and results in sustained cytotoxic T-lymphocyte activation and tumor protection","volume":"32","author":"T Warger","year":"2007","journal-title":"Clinic Rev Allerg Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.4049\/jimmunol.180.3.1991","article-title":"Tumor immunotherapy by epicutaneous immunization requires langerhans cells","volume":"180","author":"P Stoitzner","year":"2008","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e27911","DOI":"10.1371\/journal.pone.0027911","article-title":"Regulatory T Cells and IL-10 Independently Counterregulate Cytotoxic T Lymphocyte Responses Induced by Transcutaneous Immunization","volume":"6","author":"P Stein","year":"2011","journal-title":"PLoS ONE"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.134.1.25","article-title":"Self-administered topical 5% imiquimod cream for external anogenital warts","volume":"134","author":"L Edwards","year":"1998","journal-title":"Arch Dermatol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D34VW339W4","article-title":"Imiquimod 5 percent cream and the treatment of cutaneous malignancy","volume":"10","author":"D Navi","year":"2004","journal-title":"Dermatol Online J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"776","DOI":"10.4049\/jimmunol.181.1.776","article-title":"Immunization of malignant melanoma patients with full-length NY-ESO-1 protein using TLR7 agonist imiquimod as vaccine adjuvant","volume":"181","author":"S Adams","year":"2008","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/pros.20941","article-title":"Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer","volume":"69","author":"S Feyerabend","year":"2009","journal-title":"Prostate"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/bdd.1787","article-title":"Comparative transcutaneous immunization with imiquimod-containing ointments and potential of in vitro methods to predict effects","volume":"33","author":"K Gogoll","year":"2012","journal-title":"Biopharm Drug Dispos"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/ncomms2566","article-title":"Aldara activates TLR7-independent immune defence","volume":"4","author":"A Walter","year":"2013","journal-title":"Nat Comms"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1084\/jem.169.3.1169","article-title":"Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells","volume":"169","author":"N Romani","year":"1989","journal-title":"J Exp Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0264-410X(99)00434-X","article-title":"Vaccines in historic evolution and perspective: a narrative of vaccine discoveries","volume":"18","author":"MR Hilleman","year":"2000","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/nrc3153","article-title":"Novel cancer immunotherapy agents with survival benefit: recent successes and next steps","volume":"11","author":"P Sharma","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer","volume":"363","author":"PW Kantoff","year":"2010","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, <etal>et al<\/etal>.. (2012) Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med. doi:10.1038\/nm.2883.","DOI":"10.1038\/nm.2883"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1248\/bpb.34.586","article-title":"Characterization of Transcutaneous Protein Delivery by a Hydrogel Patch in Animal, Human, and Tissue-Engineered Skin Models","volume":"34","author":"K Matsuo","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.vaccine.2013.03.022","article-title":"Frontiers of transcutaneous vaccination systems: novel technologies and devices for vaccine delivery","volume":"31","author":"K Matsuo","year":"2013","journal-title":"Vaccine"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejpb.2008.11.001","article-title":"Follicular transport route \u2013 Research progress and future perspectives","volume":"71","author":"F Knorr","year":"2009","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1182\/blood-2005-10-4015","article-title":"Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo","volume":"108","author":"T Warger","year":"2006","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nm0398-328","article-title":"Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells","volume":"4","author":"FO Nestle","year":"1998","journal-title":"Nat Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/bmc.1075","article-title":"Development and validation of HPLC method for imiquimod determination in skin penetration studies","volume":"22","author":"DD Paula","year":"2008","journal-title":"Biomed Chromatogr"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0102664","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T04:12:38Z","timestamp":1649650358000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0102664"}},"subtitle":[],"editor":[{"given":"Hiroshi","family":"Shiku","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,15]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0102664","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,15]]}}}